ABSTRACT
SLC12A5, a neuron-specific potassium-chloride co-transporter, has been reported to promote tumor progression, however, the underlying mechanism remains unclear. Here we report that SLC12A5 functions as an oncogene to promote tumor progression and castration resistance of prostate cancer through the N6-methyladenosine (m6A) reader YTHDC1 and the transcription factor HOXB13. We have shown that the level of SLC12A5 was increased in prostate cancer, in comparison to its normal counterparts, and further elevated in castration-resistant prostate cancer (CRPC). The enhanced expression of SLC12A5 mRNA was associated with neuroendocrine prostate cancer (NEPC) progression and poor survival in prostate cancer. Furthermore, we demonstrated that SLC12A5 promoted the castration resistance development of prostate cancer in addition to the cell proliferation and migration. Interestingly, SLC12A5 was detected in the cell nucleus and formed a complex with nuclear m6A reader YTHDC1, which in turn upregulated HOXB13 to promote the prostate cancer progression. Therefore, our findings reveal a mechanism that how the potassium-chloride cotransporter SLC12A5 promotes the tumor progression and provide a therapeutic opportunity for prostate cancer to apply the neurological disorder drug SLC12A5 inhibitors.
Subject(s)
Prostatic Neoplasms, Castration-Resistant , Symporters , Male , Humans , Prostatic Neoplasms, Castration-Resistant/pathology , Symporters/genetics , Symporters/metabolism , Chlorides/metabolism , Chlorides/therapeutic use , Castration , Potassium/metabolism , Cell Line, Tumor , Gene Expression Regulation, Neoplastic , RNA Splicing Factors/metabolism , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolismABSTRACT
BACKGROUND: The burden of kidney, bladder, and prostate cancers has changed in recent decades. This study aims to investigate the global and regional burden of, and attributable risk factors for genitourinary cancers during the past 30 years. METHODS: We extracted data of kidney, bladder, and prostate cancers from the Global Burden of Disease 2019 database, including incidence, mortality, disability-adjusted life-years (DALYs), and attributable risk factors from 1990 to 2019. Estimated annual percentage changes (EAPC) were calculated to assess the changes in age-standardized incidence rate, age-standardized mortality rate (ASMR), and age-standardized DALYs rate (ASDR). The associations between cancers burden and socio-demographic index (SDI) were also analyzed. RESULTS: Compared with 1990, the global incident cases in 2019 were higher by 154.78%, 123.34%, and 169.11% for kidney, bladder, and prostate cancers, respectively. During the 30-year study period, there was a downward trend in ASMR and ASDR for bladder cancer (EAPC = - 0.68 and - 0.83, respectively) and prostate cancer (EAPC = - 0.75 and - 0.71, respectively), but an upward trend for kidney cancer (EAPC = 0.35 and 0.12, respectively). Regions and countries with higher SDI had higher incidence, mortality, and DALYs for all three types of cancers. The burden of bladder and prostate cancers was mainly distributed among older men, whereas the burden of kidney cancer increased among middle-aged men. Smoking related mortality and DALYs decreased, but high body mass index (BMI) and high fasting plasma glucose (FPG) related mortality and DALYs increased among kidney, bladder, and prostate cancers during the study period. CONCLUSIONS: Kidney, bladder, and prostate cancers remain major global public health challenges, but with distinct trend for different disease entity across different regions and socioeconomic status. More proactive intervention strategies, at both the administrative and academic levels, based on the dynamic changes, are needed.
Subject(s)
Prostatic Neoplasms , Urinary Bladder , Aged , Global Burden of Disease , Humans , Kidney , Male , Middle Aged , Prostatic Neoplasms/epidemiology , Quality-Adjusted Life Years , Risk FactorsABSTRACT
Background: The morbidity and mortality of coronavirus disease 2019 (COVID-19) are still increasing. This study aimed to assess the quality of relevant COVID-19 clinical practice guidelines (CPGs) and to compare the similarities and differences between recommendations. Methods: A comprehensive search was conducted using electronic databases (PubMed, Embase, and Web of Science) and representative guidelines repositories from December 1, 2019, to August 11, 2020 (updated to April 5, 2021), to obtain eligible CPGs. The Appraisal of Guidelines for Research and Evaluation (AGREE II) tool was used to evaluate the quality of CPGs. Four authors extracted relevant information and completed data extraction forms. All data were analyzed using R version 3.6.0 software. Results: In total, 39 CPGs were identified and the quality was not encouragingly high. The median score (interquartile range, IQR) of every domain from AGREE II for evidence-based CPGs (EB-CPGs) versus (vs.) consensus-based CPG (CB-CPGs) was 81.94% (75.00-84.72) vs. 58.33% (52.78-68.06) in scope and purpose, 59.72% (38.89-75.00) vs. 36.11% (33.33-36.11) in stakeholder involvement, 64.58% (32.29-71.88) vs. 22.92% (16.67-26.56) in rigor of development, 75.00% (52.78-86.81) vs. 52.78% (50.00-63.89) in clarity of presentation, 40.63% (22.40-62.50) vs. 20.83% (13.54-25.00) in applicability, and 58.33% (50.00-100.00) vs. 50.00% (50.00-77.08) in editorial independence, respectively. The methodological quality of EB-CPGs were significantly superior to the CB-CPGs in the majority of domains (P < 0.05). There was no agreement on diagnosis criteria of COVID-19. But a few guidelines show Remdesivir may be beneficial for the patients, hydroxychloroquine +/- azithromycin may not, and there were more consistent suggestions regarding discharge management. For instance, after discharge, isolation management and health status monitoring may be continued. Conclusions: In general, the methodological quality of EB-CPGs is greater than CB-CPGs. However, it is still required to be further improved. Besides, the consistency of COVID-19 recommendations on topics such as diagnosis criteria is different. Of them, hydroxychloroquine +/- azithromycin may be not beneficial to treat patients with COVID-19, but remdesivir may be a favorable risk-benefit in severe COVID-19 infection; isolation management and health status monitoring after discharge may be still necessary. Chemoprophylaxis, including SARS-CoV 2 vaccines and antiviral drugs of COVID-19, still require more trials to confirm this.
ABSTRACT
OBJECTIVE: To explore the effect of modified Brisson surgery combined with the skin flap clipping technique in the treatment of severe concealed penis in children. METHODS: We retrospectively analyzed the clinical data on 165 children with severely concealed penis treated in our hospital from January 2014 to January 2019, 105 by modified Brisson surgery combined with the skin flap clipping technique and the other 60 by modified Devine surgery, all the operations performed by the same surgeon. We compared the two surgical strategies concerning operation time, intraoperative blood loss, postoperative increase of penile exposure, preputial edema duration, flap necrosis and penile retraction, and satisfaction of the patients' parents with the overall surgical effect. RESULTS: No injury of the dorsal nerve or urethra, nor postoperative refractory prepuce edema or painful erection was found in any of the cases. The patients treated by modified Brisson surgery, in comparison with those treated by modified Devine surgery, showed significantly less intraoperative blood loss (ï¼»8.4 ± 1.60ï¼½ vs ï¼»12.6 ± 2.10ï¼½ ml, P < 0.05), more postoperative increase of penile exposure (ï¼»2.7 ± 0.29ï¼½ vs ï¼»2.3 ± 0.22ï¼½ cm, P < 0.05), fewer cases of flap necrosis (1 vs 4, P < 0.05) and higher rate of satisfaction with the overall surgical effect (94.9% vs 84.5%, P < 0.05), but there were no statistically significant differences between the former and the latter groups in the operation time (ï¼»48.3 ± 4.1ï¼½ vs ï¼»48.1 ± 5.0ï¼½ min, P > 0.05) or the postoperative duration of prepuce edema (ï¼»3.3 ± 0.93ï¼½ vs ï¼»3.2 ± 0.90ï¼½ d, P > 0.05) or number of cases of penile retraction at 6 months (1 vs 1, P > 0.05). CONCLUSIONS: Modified Brisson surgery combined with the skin flap clipping technique can achieve satisfactory results in the treatment of severe concealed penis in children and therefore deserves to be popularized in clinical application.
Subject(s)
Genital Diseases, Male/surgery , Penis/surgery , Plastic Surgery Procedures , Surgical Flaps , Urologic Surgical Procedures, Male , Child , Humans , Male , Retrospective StudiesABSTRACT
AIM: To investigate the prognostic significance of perioperative leukopenia in patients with resected gastric cancer. METHODS: A total of 614 eligible gastric cancer patients who underwent curative D2 gastrectomy and adjuvant chemotherapy were enrolled in this study. The relationship between pre- and postoperative hematologic parameters and overall survival was assessed statistically, adjusted for known prognostic factors. RESULTS: The mean white blood cell count (WBC) significantly decreased after surgery, and 107/614 (17.4%) patients developed p-leukopenia, which was defined as a preoperative WBC ≥ 4.0 × 10(9)/L and postoperative WBC < 4.0 × 10(9)/L, with an absolute decrease ≥ 0.5 × 10(9)/L. The neutrophil count decreased significantly more than the lymphocyte count. P-leukopenia significantly correlated with poor tumor differentiation and preoperative WBC. A higher preoperative WBC and p-leukopenia were independent negative prognostic factors for survival [hazard ratio (HR) = 1.602, 95% confidence interval (CI): 1.185-2.165; P = 0.002, and HR = 1.478, 95%CI: 1.149-1.902; P = 0.002, respectively] after adjusting for histology, Borrmann type, pTNM stage, vascular or neural invasion, gastrectomy method, resection margins, chemotherapy regimens, and preoperative WBC count. The patients with both higher preoperative WBC and p-leukopenia had a worse prognosis compared to those with lower baseline WBC and no p-leukopenia (27.5 mo vs 57.3 mo, P < 0.001). CONCLUSION: Preoperative leukocytosis alone or in combination with postoperative leukopenia could be independent prognostic factors for survival in patients with resectable gastric cancer.
Subject(s)
Gastrectomy , Leukocytosis/blood , Leukopenia/blood , Stomach Neoplasms/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Chemotherapy, Adjuvant , Chi-Square Distribution , Female , Gastrectomy/adverse effects , Humans , Kaplan-Meier Estimate , Leukocyte Count , Leukocytosis/diagnosis , Leukocytosis/mortality , Leukopenia/diagnosis , Leukopenia/mortality , Male , Medical Records , Middle Aged , Multivariate Analysis , Neoplasm Staging , Perioperative Period , Predictive Value of Tests , Proportional Hazards Models , Retrospective Studies , Risk Factors , Stomach Neoplasms/blood , Stomach Neoplasms/mortality , Stomach Neoplasms/pathology , Time Factors , Treatment Outcome , Young AdultABSTRACT
The Arabidopsis thaliana lysyl tRNA synthetase (AtKRS) structurally and functionally resembles the well-characterized prokaryotic class IIb KRS, including the propensity to aminoacylate tRNA(Lys) with suboptimal identity elements, as well as non-cognate tRNAs. Transient expression of AtKRS in carrot cells promotes aminoacylation of such tRNAs in vivo and translational recoding of lysine at nonsense codons. Stable expression of AtKRS in Zea mays causes translational recoding of lysine into zeins, significantly enriching the lysine content of grain.